Pharos iBio Co., Ltd.
AI-powered drug development for rare and refractory diseases, focusing on oncology.
388870 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안양시 동안구 흥안대로427번길 38, 1408호(관양동, 성지스타위드), 안양시
- Website:
- https://www.pharosibio.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Pharos iBio Co., Ltd. is a clinical-stage biotechnology company specializing in the development of novel drugs for rare and refractory diseases, with a particular focus on oncology. The company leverages its proprietary artificial intelligence (AI) and big data platform, Chemiverse®, to accelerate the drug discovery and development process. This platform integrates multiple modules, including protein structure analysis, to identify and optimize new drug candidates from target identification through to the preclinical stage. The company has successfully advanced its AI-developed therapies into clinical trials, notably for conditions like acute myeloid leukemia (AML), aiming to provide innovative treatments for patients with high unmet medical needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Pharos iBio Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Pharos iBio Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharos iBio Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
